{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:05:05Z","timestamp":1791518705504,"version":"4.3.4"},"reference-count":11,"publisher":"Informa UK Limited","issue":"16","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007174","name":"Array BioPharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007174","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2025,7,3]]},"DOI":"10.1080\/14796694.2025.2514426","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T09:41:23Z","timestamp":1749721283000},"page":"1961-1963","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["POLARIS: encorafenib plus binimetinib for people with BRAF                    V600-mutant melanoma with brain metastasis"],"prefix":"10.1080","volume":"21","author":[{"given":"Alexander M.","family":"Menzies","sequence":"first","affiliation":[{"name":"The University of Sydney, and Royal North Shore and Mater Hospitals","place":["Sydney, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Davies","sequence":"additional","affiliation":[{"name":"University of Texas MD Anderson Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061640"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4438"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-020-00733-z"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.69"},{"key":"e_1_3_6_7_1","unstructured":"US Food and Drug Administration (FDA). BRAFTOVI\u00ae (encorafenib). Prescribing Information. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/210496s013lbl.pdf"},{"key":"e_1_3_6_8_1","unstructured":"European Medicines Agency (EMA). BRAFTOVI\u00ae (encorafenib). Summary of Product Characteristics. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/braftovi-epar-product-information_en.pdf"},{"key":"e_1_3_6_9_1","unstructured":"US Food and Drug Administration (FDA). MEKTOVI\u00ae (binimetinib). Prescribing Information. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210498lbl.pdf"},{"key":"e_1_3_6_10_1","unstructured":"European Medicines Agency (EMA). MEKTOVI\u00ae (binimetinib). Summary of Product Characteristics. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/mektovi-epar-product-information_en.pdf"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30429-1"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3550"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31889"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2025.2514426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T14:21:15Z","timestamp":1763043675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2025.2514426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":11,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025,7,3]]}},"alternative-id":["10.1080\/14796694.2025.2514426"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2025.2514426","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-01-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}